How To Use The UK’s New International Recognition Pathway For Drug Approvals

 
• By Neena Brizmohun

Eligibility criteria, how to apply, 60-day and 110-day timetables, major objections and clock stops. These are among the topics that the Medicines and Healthcare products Regulatory Agency covers in newly published guidance for drug companies planning to use the soon to be launched IRP.

The MHRA's IRP will leverage the decision-making of trusted regulatory partners • Source: Shutterstock

More from United Kingdom

More from Europe